Tantum Verde Forte oropharyngeal spray 0.3%, 15 ml, CSC Pharmaceuticals

Tantum Verde strong oropharyngeal spray 0.3%, 15 ml, CSC Pharmaceuticals

It is indicated in the anti-inflammatory and analgesic treatment of inflammatory conditions of the oropharyngeal mucosa (stomatitis, pharyngitis) and gums.

It is also indicated in dentistry, after tooth extractions.

Indications:

• Tantum Verde Forte 3mg/ml oropharyngeal spray
• It quickly reduces the pain associated with inflammatory conditions of the oropharyngeal mucosa, having anti-inflammatory, analgesic, anesthetic and antiseptic effects
• Anti-inflammatory and analgesic treatment of inflammatory diseases of the oropharyngeal mucosa (stomatitis, pharyngitis) and gums
• Tantum Verde spray is also indicated in dentistry after tooth extractions
• For adults
• Used for: anti-inflammatory and analgesic treatment of inflammatory conditions of the oropharyngeal mucosa (stomatitis, pharyngitis) and gums
• Conditions: inflammatory conditions of the oropharyngeal mucosa (stomatitis, pharyngitis) and of the gums, including after dental extractions.

Composition:

100 ml oropharyngeal spray contains benzidamine hydrochloride 0.30 g and excipients: ethanol 96%, glycerol, methyl p-hydroxybenzoate, hydrogenated castor oil, mint flavor, sodium saccharin, purified water.

Administration method:

Adults: 2-4 doses 2-6 times daily (each dose contains 0.17 ml of benzidamine hydrochloride).

Contradictions:

Hypersensitivity to benzidamine hydrochloride or any of the product's excipients.

Precautions:

• Prolonged use may produce sensitization phenomena. In this case, the treatment with Tantum Verde Forte spray 0.3% must be stopped and an appropriate treatment instituted, after specialist consultation
• If results are not obtained after a short period of treatment with benzidamine, both diagnosis and treatment should be reevaluated
• Tantum Verde Forțe spray 0.3% is recommended for patients who have difficulty gargling
• Interactions with other medicinal products, other interactions
• No interactions with other drugs used concurrently for the same indications have been reported.

Presentation: 15 ml